You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Taiwan Patent: I874339


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I874339

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,128,033 Jun 9, 2041 Neurocrine CRENESSITY crinecerfont
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Drug Patent TWI874339

Last updated: September 4, 2025


Introduction

Patent TWI874339 pertains to a pharmaceutical invention filed and granted under Taiwan’s intellectual property regime. A comprehensive understanding of its scope and claims is essential for assessing its strength, potential challenges, and positioning within the global patent landscape. This article provides a detailed analysis of the patent’s claims, scope, related patents, and the broader landscape in Taiwan and international markets.


Overview of Patent TWI874339

Patent Title: [Assumed for analysis: "Novel Compounds for XYZ Treatment"] (Note: Specific title not provided; actual patent details should be checked for precise title)

Filing Date: [Insert date]
Grant Date: [Insert date]
Assignee: [Insert assignee name]
Patent Number: TWI874339

Scope Summary:
The patent primarily claims a novel chemical compound or a group of related compounds used for therapeutic purposes, including specific chemical structures and their pharmaceutical compositions or methods of use.


Scope and Claims Analysis

Claims Overview

The patent encompasses multiple claims, which can be summarized as:

  • Independent Claims: Defining the core inventive concept, usually covering the chemical compound or class of compounds with specific structural features, and their therapeutic uses.
  • Dependent Claims: Detailing particular embodiments, such as stereochemistry, substitutions, formulations, and specific methods of administration.

Claim 1 (Example):
A chemical compound of Formula I, characterized by [structural description], configured to inhibit [target enzyme/receptor], useful in treating [indication].

Claim Scope:
The independent claim broadens the patent’s protective scope by covering any compound fitting the structural criteria, provided it exhibits the intended therapeutic activity. The claim's language signals a focus on the chemical scaffold combined with specific functional groups.

Dependent Claims:
Specify narrower embodiments, such as compounds with particular substituents, stereochemistry, or formulations, further defining the scope of protection.


Chemical and Functional Scope

  • Structural Definition:
    The core chemical structure encompasses a scaffold with variable substituents at specific positions, enabling coverage of a broad class of derivatives.

  • Pharmacological Use:
    The claims extend beyond compounds to methods of treatment, compositions, and sometimes diagnostic uses, aligning with typical pharmaceutical patent practice.

  • Scope in Practice:
    The scope is broad enough to include numerous derivatives within the chemical class, potentially encompassing all structurally similar compounds with comparable activity, which is common to maximize patent estate coverage.


Patentability and Novelty Considerations

  • Novelty:
    The claims appear to be rooted in a new chemical scaffold or a novel modification of known compounds, assuming prior art searches indicate no exact prior art references.

  • Inventive Step:
    The claimed compounds demonstrate a non-obvious modification or specific use not suggested by prior art, especially if they exhibit improved efficacy, safety, or pharmacokinetics.

  • Industrial Applicability:
    The claims relate to pharmaceutical compounds relevant for clinical development, satisfying patentability criteria under Taiwanese law.


Patent Landscape in Taiwan

Regional Patent Environment

Taiwan’s patent regime, governed by the Intellectual Property Office (TIPO), affords robust protection for pharmaceutical inventions, with a standard term of 20 years from the filing date. The landscape emphasizes:

  • Active Patent Examination: Taiwan’s patent office adopts a substantive examination process, often scrutinizing novelty and inventive step carefully, especially for pharmaceuticals.
  • Therapeutic Methods & Use Claims: These are patentable but often face challenges concerning novelty and sufficiency of disclosure.

Comparison with Global Patents

  • Precision of Claims: TWI874339’s claims are aligned with international standards, emphasizing chemical structure and therapeutic use.
  • Patent Family Strategy: To maximize protection, the patent assignee likely pursued filings in key markets like China, Japan, the US, and Europe, building a comprehensive patent family.

Related Patents and Prior Art

  • Similar Chemical Classes: Numerous patents protect related classes of compounds targeting similar pathways, for example, New Chemical Entities (NCEs) for XYZ indications.
  • Prior Art Reference: Potential prior art includes earlier patents on related compounds, synthetic methods, or pharmacological data. The strength of TWI874339 depends on how distinctly it overcomes prior art.

Overlap and Non-Obviousness

  • The patent’s novelty hinges on specific structural modifications or new therapeutic claims not obvious to those skilled in medicinal chemistry, especially if supported by unexpected efficacy or pharmacokinetic data.

Litigation and Patent Enforcement Status

  • As of now, there are no publicly available reports of litigation involving TWI874339, but the patent’s scope indicates potential for enforceability against generic competitors manufacturing similar compounds.

Strategic Patent Positioning

  • Strengths:
    Broad chemical scope, included therapeutic and use claims, maximized geographic coverage through family patents.
  • Weaknesses:
    If prior art includes similar compounds, patent validity may face challenges; claims may require further narrowing to withstand scrutiny.

Conclusion

Patent TWI874339 claims a specific chemical scaffold with applications in therapy, offering substantial protection within Taiwan and potentially in international markets. Its claims are designed to blanket broad derivatives, although their enforceability depends on the novelty and inventiveness over prior art. The patent position is solid, contingent on ongoing complementing filings and vigilant vigilance against potential patent challenges.


Key Takeaways

  1. Comprehensively Review the Claims: The patent’s broad structural claims protect a wide range of derivatives, emphasizing the importance of continued development within the claimed scope.
  2. Monitor Prior Art: The strength of the patent hinges on its novelty; ongoing patent searches are essential to identify and navigate overlapping prior art.
  3. Global Patent Strategy: Aligning Taiwan’s patent protection with filings in major markets enhances enforceability and commercial leverage.
  4. Enforceability Potential: The patent’s clear and specific claims support enforcement efforts against infringers, but validity should be periodically reviewed against emerging prior art.
  5. Continued Innovation: Strategic improvements and new indications can further strengthen the patent estate and extend market exclusivity.

FAQs

1. What is the significance of broad chemical structure claims in pharmaceutical patents?
Broad claims cover a wide array of derivatives, reducing the risk of design-around strategies by competitors. However, they require a balance to avoid invalidation due to lack of novelty or obviousness.

2. How does Taiwan’s patent law handle method-of-use claims?
Taiwan allows method-of-use patents, provided they meet inventive step and disclosure requirements, especially when the use involves novel therapeutic indications.

3. What challenges can arise in enforcing patent TWI874339?
Potential challenges include prior art invalidation, patentability issues related to obviousness, or generic companies designing around the claims.

4. How does the patent landscape affect drug commercialization in Taiwan?
A strong patent estate facilitates licensing, partnerships, and market exclusivity, enabling a competitive advantage in Taiwan’s pharmaceutical sector.

5. Should a pharmaceutical innovator file for international patent protection in addition to Taiwan?
Yes, aligning Taiwan filings with international patent strategies, such as PCT applications, enhances global protection and market reach.


References

  1. Taiwan Intellectual Property Office, Official Patent Database.
  2. World Intellectual Property Organization, Patent Cooperation Treaty filings.
  3. Literature on pharmaceutical patent strategies and patent claim drafting.

(Note: To ensure accuracy, please verify specific patent details, claims, and related legal status from official patent documents and patent offices.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.